Positron (OTCMKTS:POSC – Get Free Report) is one of 78 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its competitors? We will compare Positron to similar businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, profitability, earnings and dividends.
Risk and Volatility
Positron has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Positron’s competitors have a beta of 0.92, suggesting that their average stock price is 8% less volatile than the S&P 500.
Institutional and Insider Ownership
44.3% of shares of all “Electromedical equipment” companies are owned by institutional investors. 17.2% of Positron shares are owned by insiders. Comparatively, 15.1% of shares of all “Electromedical equipment” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings and Valuation
Gross Revenue | Net Income | Price/Earnings Ratio | |
Positron | $740,000.00 | -$1.64 million | -12.13 |
Positron Competitors | $974.05 million | $81.52 million | 9.84 |
Positron’s competitors have higher revenue and earnings than Positron. Positron is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Positron and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Positron | -300.00% | N/A | -89.57% |
Positron Competitors | -299.08% | -83.96% | -27.59% |
Analyst Recommendations
This is a summary of recent ratings and target prices for Positron and its competitors, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Positron | 0 | 0 | 0 | 0 | N/A |
Positron Competitors | 287 | 826 | 2136 | 109 | 2.62 |
As a group, “Electromedical equipment” companies have a potential upside of 2,878.01%. Given Positron’s competitors higher probable upside, analysts plainly believe Positron has less favorable growth aspects than its competitors.
Summary
Positron competitors beat Positron on 8 of the 10 factors compared.
Positron Company Profile
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Receive News & Ratings for Positron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Positron and related companies with MarketBeat.com's FREE daily email newsletter.